Biofil Chemicals and Pharmaceuticals Limited

NSE BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited Debt to Equity Ratio for the year ending March 31, 2024: 0.02

Biofil Chemicals and Pharmaceuticals Limited Debt to Equity Ratio is 0.02 for the year ending March 31, 2024, a -20.13% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Biofil Chemicals and Pharmaceuticals Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.03, a 9.38% change year over year.
Biofil Chemicals and Pharmaceuticals Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.03, a 3.57% change year over year.
Biofil Chemicals and Pharmaceuticals Limited Debt to Equity Ratio for the year ending March 31, 2021 was 0.03.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

NSE: BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited

CEO	Mr. Ramesh S. Shah
IPO Date	July 27, 2017
Location	India
Headquarters	11/12, Sector "E"
Employees	26
Sector	Materials
Industries Fertilizers Chemicals & Advanced Materials Drugstores & Retail Pharmacies Petrochemicals Pharmaceuticals

Description

Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. The company was incorporated in 1985 and is based in Indore, India.

Key trends

Past 5 years